Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03894007Phase 2Terminated
Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer
Early-stage Breast CancerHER2-positive Breast Cancer
PrincipalinvestigatorStart date: 2019-05-23

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Karolinska University Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhimin Shao, Professor

Fudan University

Moderately Similar
5 trials

Shared therapeutic areas:

Early-stage Breast CancerHER2-positive Breast Cancer
Similarity Score30%

shu wang, doctor

Peking University People's Hospital

Moderately Similar
9 trials

Shared therapeutic areas:

Early-stage Breast CancerHER2-positive Breast Cancer
Similarity Score30%

Jonas Bergh, MD, PhD

Karolinska Institutet

Related
2 trials

Shared therapeutic areas:

Early-stage Breast CancerHER2-positive Breast Cancer

Worked with same sponsors:

Renske Altena
Collaborated on 1 trial
Similarity Score24%

Jonathan McConathy, MD, PhD

University of Alabama at Birmingham

Related
6 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Early-stage Breast Cancer
Similarity Score15%

Kamran Ahmed, MD

Moffitt Cancer Center

Related
4 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Shanu Modi, MD

Memorial Sloan Kettering Cancer Center

Related
6 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Qamar Khan, MD

University of Kansas Medical Center

Related
4 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Kun Wang, MD

Guangdong Provincial People's Hospital

Related
6 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

François-Clément Bidard

Institut Curie

Related
4 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03894007Phase 2PrincipalInvestigator

Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer

Early-stage Breast CancerHER2-positive Breast Cancer
Terminated

All 1 trials loaded